Profile data is unavailable for this security.
About the company
Shanghai Aladdin Biochemical Technology Co Ltd is a China-based company mainly engaged in the research and development, production and sales of scientific research reagents. The Company's businesses cover the four major areas of high-end chemistry, life sciences, analytical chromatography and materials science, and a small amount of experimental consumables. The Company's products are used in universities, scientific research institutes, biomedicine, new materials, new energy, energy conservation and environmental protection, aerospace and other fields. The Company independently builds Aladdin brand scientific research reagents and Silicon Valley brand experimental consumables, mainly relying on its own e-commerce platform www.aladdin-e.com to achieve online sales. The Company mainly conducts its businesses in the China market.
- Revenue in CNY (TTM)414.81m
- Net income in CNY85.68m
- Incorporated2009
- Employees566.00
- LocationShanghai Aladdin Biochemical Technology Co Ltd16F, South Tower, No. 36Xinjinqiao Road, Pudong New AreaSHANGHAI 201206ChinaCHN
- Phone+86 2 150560989
- Fax+86 2 150323701
- Websitehttps://www.aladdin-e.com/
More ▼
Mergers & acquisitions
| Acquired company | 688179:SHH since announced | Transaction value |
|---|---|---|
| Shanghai Yuanye Bio-Technology Co Ltd | -25.92% | 25.13m |
Data delayed at least 15 minutes, as of May 31 2024 08:00 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hinova Pharmaceuticals Inc | 0.00 | -266.00m | 3.00bn | 179.00 | -- | 2.26 | -- | -- | -2.69 | -2.69 | 0.00 | 13.39 | 0.00 | 105.68 | -- | 0.00 | -17.03 | -31.86 | -18.39 | -37.18 | -- | -- | -- | -25,578.24 | 11.83 | -- | 0.0097 | -- | -100.00 | -- | 2.44 | -- | 124.37 | -- |
| Bide Pharmatech Co Ltd | 1.10bn | 98.72m | 3.01bn | 846.00 | 30.44 | 1.47 | -- | 2.73 | 1.09 | 1.09 | 12.14 | 22.50 | 0.4585 | 1.09 | 4.76 | 1,302,686.00 | 4.06 | -- | 4.62 | -- | 38.38 | -- | 8.86 | -- | 5.29 | -- | 0.0416 | -- | 30.94 | -- | -24.94 | -- | -- | -- |
| Shanghai ZJ Bio-Tech Co Ltd | 241.21m | -115.98m | 3.01bn | 305.00 | -- | 0.7749 | -- | 12.50 | -0.6443 | -0.6443 | 1.26 | 19.98 | 0.0563 | 0.2057 | 1.59 | 790,860.40 | -2.71 | 17.08 | -2.87 | 19.18 | 67.55 | 60.21 | -48.08 | 34.13 | 14.96 | -- | 0.0016 | 34.15 | -88.21 | 4.10 | -118.00 | -- | 35.93 | -- |
| Hangzhou Biotest Biotech Co Ltd | 474.05m | 134.34m | 3.04bn | 629.00 | 22.47 | 1.24 | -- | 6.42 | 1.27 | 1.27 | 4.48 | 23.08 | 0.1788 | 2.17 | 8.38 | 753,658.60 | 5.03 | 29.45 | 5.32 | 33.30 | 49.40 | 56.83 | 28.13 | 41.59 | 13.02 | -- | 0.0009 | 29.32 | -76.75 | 19.65 | -86.22 | 41.33 | 34.82 | -- |
| Shanghai Aladdin Biochemical Tech Co Ltd | 414.81m | 85.68m | 3.08bn | 566.00 | 30.79 | 2.92 | -- | 7.42 | 0.3602 | 0.3602 | 1.38 | 3.80 | 0.2803 | 0.3898 | 9.21 | 732,874.10 | 5.79 | 8.83 | 6.20 | 9.61 | 60.08 | 61.49 | 20.66 | 26.85 | 8.00 | -- | 0.2519 | 45.71 | 6.55 | 19.36 | -7.48 | 9.95 | 31.41 | -- |
| Zhejiang Shapuaisi Pharmaceutical Co Ltd | 620.60m | 7.18m | 3.13bn | 1.39k | 287.16 | 1.78 | -- | 5.04 | 0.0287 | 0.0287 | 1.63 | 4.64 | 0.2983 | 3.65 | 20.26 | 448,088.40 | 0.3351 | -0.7573 | 0.3914 | -0.8713 | 53.99 | 58.02 | 1.12 | -2.45 | 0.8316 | -- | 0.1046 | -- | 17.37 | 1.21 | -43.23 | -- | 30.36 | -- |
| Shanghai Shenqi Pharmactcl Inv Mgt CoLtd | 2.33bn | 57.15m | 3.20bn | 1.43k | 53.42 | 1.40 | -- | 1.37 | 0.1159 | 0.1159 | 4.37 | 4.42 | 0.7213 | 5.74 | 5.75 | 1,635,818.00 | 1.86 | -0.6002 | 2.33 | -0.7417 | 47.59 | 56.64 | 2.57 | -0.9128 | 2.34 | 12.17 | 0.104 | -- | -2.00 | 4.79 | 17.41 | -11.68 | -25.97 | -- |
Data as of May 31 2024. Currency figures normalised to Shanghai Aladdin Biochemical Technology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
14.32%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Zhong Ou Asset Management Co., Ltdas of 30 Sep 2022 | 6.89m | 6.67% |
| Huashang Fund Management Co., Ltd.as of 31 Dec 2023 | 3.87m | 3.75% |
| Aegon-Industrial Capital Management (Shanghai) Co. Ltd.as of 30 Sep 2022 | 1.61m | 1.56% |
| GF Fund Management Co., Ltd.as of 31 Dec 2023 | 1.38m | 1.34% |
| Lion Fund Management Co., Ltd.as of 31 Dec 2023 | 334.78k | 0.32% |
| JX Asset Management Co.,Ltdas of 31 Dec 2023 | 279.35k | 0.27% |
| China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 179.63k | 0.17% |
| First-Trust Fund Management Co., Ltd.as of 31 Dec 2023 | 135.99k | 0.13% |
| Golden Trust Sinopac Fund Management Co., Ltd.as of 31 Dec 2023 | 70.00k | 0.07% |
| Orient Fund Management Co., Ltd.as of 31 Dec 2023 | 35.00k | 0.03% |
More ▼
Data from 30 Sep 2022 - 31 Mar 2024Source: FactSet Research Systems Inc.
